These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15755941)

  • 1. Carvedilol, metoprolol, and insulin resistance.
    Gonzalez-Feldman E
    JAMA; 2005 Mar; 293(10):1190; author reply 1190. PubMed ID: 15755941
    [No Abstract]   [Full Text] [Related]  

  • 2. Current concepts of pharmacotherapy in hypertension. Carvedilol: new considerations for its use in the diabetic patient with hypertension.
    Sica DA
    J Clin Hypertens (Greenwich); 2005 Jan; 7(1):59-64. PubMed ID: 15655391
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.
    Bank AJ; Kelly AS; Thelen AM; Kaiser DR; Gonzalez-Campoy JM
    Am J Hypertens; 2007 Jul; 20(7):777-83. PubMed ID: 17586413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.
    Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli FH; Phillips RA; Raskin P; Wright JT; Oakes R; Lukas MA; Anderson KM; Bell DS;
    JAMA; 2004 Nov; 292(18):2227-36. PubMed ID: 15536109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic analyses of the effects of carvedilol vs metoprolol on glycemic control and insulin sensitivity in patients with type 2 diabetes and hypertension in the Glycemic Effects in Diabetes Mellitus: Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) study.
    Phillips RA; Fonseca V; Katholi RE; McGill JB; Messerli FH; Bell DS; Raskin P; Wright JT; Iyengar M; Anderson KM; Lukas MA; Bakris GL;
    J Cardiometab Syndr; 2008; 3(4):211-7. PubMed ID: 19040589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How safe is carvedilol in NIDDM patients with hypertension?
    Choudhury D; Misra A
    Natl Med J India; 1998; 11(3):130-1. PubMed ID: 9707705
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI.
    Fonseca V; Bakris GL; Bell DS; McGill JB; Raskin P; Messerli FH; Phillips RA; Katholi RE; Wright JT; Waterhouse B; Lukas MA; Anderson KM;
    Diabet Med; 2007 Jul; 24(7):759-63. PubMed ID: 17451422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparate effects of carvedilol versus metoprolol treatment of stroke-prone spontaneously hypertensive rats on endothelial function of resistance arteries.
    Intengan HD; Schiffrin EL
    J Cardiovasc Pharmacol; 2000 May; 35(5):763-8. PubMed ID: 10813379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-adrenoceptor antagonists and ACE-inhibitors. Carvedilol compared with metoprolol as combination partner in cases of diabetes and hypertension].
    Frese T; Sandholzer H
    Dtsch Med Wochenschr; 2007 Nov; 132(44):2330-1. PubMed ID: 17957597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol versus cardioselective beta-blockers for the treatment of hypertension in patients with type 2 diabetes mellitus.
    Fardoun RZ
    Pharmacotherapy; 2006 Oct; 26(10):1491-500. PubMed ID: 16999659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body weight changes with beta-blocker use: results from GEMINI.
    Messerli FH; Bell DS; Fonseca V; Katholi RE; McGill JB; Phillips RA; Raskin P; Wright JT; Bangalore S; Holdbrook FK; Lukas MA; Anderson KM; Bakris GL;
    Am J Med; 2007 Jul; 120(7):610-5. PubMed ID: 17602935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive activity and effect on parameters of heart rate variability of beta-blockers carvedilol and metoprolol].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA
    Kardiologiia; 2005; 45(11):17-23. PubMed ID: 16353059
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of carvedilol and metoprolol on serum lipid concentration in diabetic hypertensive patients.
    Bell DS; Bakris GL; McGill JB
    Diabetes Obes Metab; 2009 Mar; 11(3):234-8. PubMed ID: 18564334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale and design of the Glycemic Effects in Diabetes Mellitus Carvedilol-Metoprolol Comparison in Hypertensives (GEMINI) trial.
    Bakris GL; Bell DS; Fonseca V; Katholi R; McGill J; Phillips R; Raskin P; Wright JT; Iyengar M; Holeslaw T; Anderson KM;
    J Diabetes Complications; 2005; 19(2):74-9. PubMed ID: 15745836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. After myocardial infarction carvedilol improves insulin resistance compared to metoprolol.
    Basat O; Ucak S; Seber S; Oztekin E; Altuntas Y
    Clin Res Cardiol; 2006 Feb; 95(2):99-104. PubMed ID: 16598518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of carvedilol and metoprolol on serum lipid concentrations and symptoms in patients with hyperthyroidism.
    Ozbilen S; Eren MA; Turan MN; Sabuncu T
    Endocr Res; 2012; 37(3):117-23. PubMed ID: 22571552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining the Logic of Antihypertensive Therapy: An International Symposium on Carvedilol. Paris, France, October 19, 1990.
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S1-67. PubMed ID: 8098063
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment.
    Ozaydin M; Peker O; Erdogan D; Akcay S; Yucel H; Icli A; Ceyhan BM; Sutcu R; Uysal BA; Varol E; Dogan A; Okutan H
    Clin Cardiol; 2014 May; 37(5):300-6. PubMed ID: 24477817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.
    Bakris GL; Fonseca V; Katholi RE; McGill JB; Messerli F; Phillips RA; Raskin P; Wright JT; Waterhouse B; Lukas MA; Anderson KM; Bell DS;
    Hypertension; 2005 Dec; 46(6):1309-15. PubMed ID: 16286578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol: a third-generation β-blocker should be a first-choice β-blocker.
    DiNicolantonio JJ; Hackam DG
    Expert Rev Cardiovasc Ther; 2012 Jan; 10(1):13-25. PubMed ID: 22149523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.